NCT03595449View on ClinicalTrials.gov

Lidocaine Jelly for Pain Control During Mohs Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

233

Participants

Timeline

Start Date

August 13, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions

PainSatisfaction, Consumer

Interventions

DRUG

Lidocaine jelly

lidocaine 2% jelly applied during Mohs surgery

DRUG

Surgilube

surgilube (placebo) applied during Mohs surgery

Trial Locations (1)

85259

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER

NCT03595449 - Lidocaine Jelly for Pain Control During Mohs Surgery | Biotech Hunter | Biotech Hunter